Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anastomotic Leak × Sodium Chloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 30 Neoplasms 10 Pain, Postoperative 9 Lung Neoplasms 9 Colorectal Neoplasms 9 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Brain Neoplasms 7 Stomach Neoplasms 6 Prostatic Neoplasms 5 Melanoma 5 Ovarian Neoplasms 4 Leiomyoma 4 Hemorrhage 4 Glioblastoma 4 Colonic Neoplasms 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myoma 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Fatigue 3 Delirium 3 Chronic Pain 3 Agnosia 3 Uterine Cervical Neoplasms 2

Interventions

Indocyanine Green 2 Ileostomy 2 Esophagectomy 2 obsidian 1 Water 1 Tomography, X-Ray Computed 1 Tobramycin 1 Tissue Adhesives 1 Surgical Procedures, Operative 1 Stents 1 Sodium Chloride 1 Serum Albumin, Human 1 Saline Solution 1 Robotic Surgical Procedures 1 Proctectomy 1 Neomycin 1 Neoadjuvant Therapy 1 Negative-Pressure Wound Therapy 1 Mortality 1 Metronidazole 1 Methods 1 Marital Status 1 Levofloxacin 1 Laparotomy 1 Inulin 1 Hematologic Tests 1 Fibrin Tissue Adhesive 1 Enoxaparin 1 Endoscopy 1 Enbucrilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02682485 2023-04-26

SES-DTA

University of Chicago

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon ⚡